Cargando…

Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer

Detalles Bibliográficos
Autores principales:	Schroth, Werner, Schwab, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225078/ https://www.ncbi.nlm.nih.gov/pubmed/35743702 http://dx.doi.org/10.3390/jpm12060917

Ejemplares similares

Therapeutic Targets and Personalized Medicine in Cardiac Disease
por: Vafiadaki, Elizabeth, et al.
Publicado: (2023)

Building the basis for proteomics in personalized medicine for targeted treatment
por: Kwon, Ho Jeong, et al.
Publicado: (2016)

Innovations in Personalized and Targeted Therapies for Breast Cancer
por: Harris, Eleanor E. R., et al.
Publicado: (2018)

Gasotransmitters in Biology and Medicine: Molecular Mechanisms and Drug Targets
por: Yang, Guangdong, et al.
Publicado: (2016)

Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients
por: Guo, Wei-Feng, et al.
Publicado: (2021)

Combinatorial approaches for mitigating resistance to KRAS-targeted therapies
por: Warren, Hannah R., et al.
Publicado: (2022)

Pharmacogenomics in Personalized Medicine and Drug Metabolism
por: Chang, Wei-Chiao
Publicado: (2014)

Personalized Medicine for Liver Disease: From Molecular Mechanisms to Potential Targeted Therapies
por: Bell, Aaron W.
Publicado: (2022)

Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
por: Huang, Chen-Tsung, et al.
Publicado: (2019)

The Evolving Approach to Breast Cancer: Moving toward De-Escalating Treatment and Personalized Medicine
por: Khoury, Thaer
Publicado: (2023)

Combinatory antitumor therapy by cascade targeting of a single drug
por: Liu, Aiyun, et al.
Publicado: (2020)

Pharmacogenomics: a key component of personalized therapy
por: Schwab, Matthias, et al.
Publicado: (2012)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
por: Muñoz-Torrero, Diego, et al.
Publicado: (2017)

Personalized Medicine in Asthma: Current Approach and Future Perspectives
por: Nolasco, Santi, et al.
Publicado: (2023)

Personalized Approaches for the Prevention and Treatment of Breast Cancer
por: Nabi, Hermann
Publicado: (2022)

Innovative Targeting Strategies in Drug Therapy for Inflammatory Diseases: Mechanistic Approaches
por: Chou, Duen-Suey, et al.
Publicado: (2015)

Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond
por: Cui, Longzhu, et al.
Publicado: (2023)

Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs
por: Venkova, Larisa, et al.
Publicado: (2015)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–2
por: Muñoz-Torrero, Diego, et al.
Publicado: (2017)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3
por: Mangoni, Arduino A., et al.
Publicado: (2018)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–5
por: Mangoni, Arduino A., et al.
Publicado: (2019)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–4
por: Mangoni, Arduino A, et al.
Publicado: (2018)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–7
por: Gütschow, Michael, et al.
Publicado: (2020)

Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes–6
por: Vanden Eynde, Jean Jacques, et al.
Publicado: (2019)

ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma
por: Smit, Marjon A, et al.
Publicado: (2014)

Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
por: Quan, Yuan, et al.
Publicado: (2018)

Drug‐grafted DNA as a novel chemogene for targeted combinatorial cancer therapy
por: Liu, Yuhe, et al.
Publicado: (2022)

Recent Advances in Combinatorial Optimization
por: Xu, Dehua, et al.
Publicado: (2015)

Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
por: Riccardo, Federica, et al.
Publicado: (2019)

Target and Non-Target Approaches for Food Authenticity and Traceability
por: Amaral, Joana S.
Publicado: (2021)

Early Biomarkers of Periodontitis: New Challenges for a Personalized Medicine Approach
por: Isola, Gaetano
Publicado: (2021)

Combinatorial CAR design improves target restriction
por: Köksal, Hakan, et al.
Publicado: (2020)

From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
por: Goutelle, Sylvain, et al.
Publicado: (2023)

From genomic medicine to precision medicine: highlights of 2015
por: Auffray, Charles, et al.
Publicado: (2016)

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine
por: VanderWalde, Ari
Publicado: (2021)

Metal drugs become targeted
por: Fuereder, Thorsten, et al.
Publicado: (2017)

Mitochondria-Targeted Drug Delivery
por: Kopecka, Joanna
Publicado: (2022)

Brain-Targeted Drug Delivery
por: Sousa, Flávia
Publicado: (2022)

Nanotechnology in Targeted Drug Delivery
por: Di Stefano, Antonio
Publicado: (2023)

Protein-Targeting Drug Discovery
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_imgn9s8pg0thgiddqkolu4mpsd